A randomized trial of efficacy and safety of adjunctive vitamin D in the treatment of active tuberculosis in India

Daley, Peter (2014) A randomized trial of efficacy and safety of adjunctive vitamin D in the treatment of active tuberculosis in India. Masters thesis, Memorial University of Newfoundland.

[English] PDF - Accepted Version Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission. Download (23MB)

Abstract

Background: Vitamin D supplementation may benefit patients with active tuberculosis (TB) Design: A randomized, double-blinded, placebo-controlled clinical trial comparing standard active TB treatment to active TB treatment plus supplemental high dose oral vitamin D3 was performed in India. Methods: Treatment naïve, smear positive, HIV negative, pulmonary TB patients were randomized into two equal groups. Results: 247 patients were randomized, 121 to vitamin D and 126 to placebo. Baseline characteristics in both groups were similar. 101 patients in the vitamin D arm and 110 patients in the placebo arm were analyzed. Median time to culture conversion in the vitamin D group was 43.0 days (95% C.I. = 33.3 to 52.8), as compared to was 42.0 days (33.9 to 50.1) in the placebo group (p=0.95 by log rank test). Hypercalcemia was not observed. Conclusions: Vitamin D supplementation was safe but did not influence time to culture conversion.

Actions (login required)

View Item